Home / 510(k) Clearances / K173195

510(k) K173195

DRI Hydrocodone Assay by Microgenics Corporation — Product Code DJG

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 13, 2018
Date Received
October 2, 2017
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Immunoassay, Opiates
Device Class
Class II
Regulation Number
862.3650
Review Panel
TX
Submission Type

Other clearances by Microgenics Corporation

  • K243498 — Alinity c Benzodiazepines Reagent Kit (December 11, 2024)
  • K240670 — DRI Ecstasy Plus Assay (October 30, 2024)
  • K231020 — Alinity c Tricyclic Antidepressants Reagent Kit (November 17, 2023)
  • K231007 — CEDIA Heroin Metabolite (6-AM) Assay (September 27, 2023)
  • K213875 — DRI TM Tricyclics Serum Tox Assay (December 21, 2022)
  • K211973 — DRI Cocaine Metabolite Assay (September 24, 2021)
  • K192943 — CEDIA Heroin Metabolite (6-AM) assay (December 16, 2019)
  • K190968 — CEDIA Benzodiazepine Assay (December 9, 2019)
  • DEN180030 — QMS Plazomicin Immunoassay (November 19, 2018)
  • K181499 — DRI Cocaine Metabolite Assay (July 6, 2018)

Other clearances for product code DJG

  • K252684 — Labcorp Fentanyl Urine Visual Test (January 29, 2026)
  • K250741 — Evidence MultiSTAT DOA Urine MultiPlex (January 23, 2026)
  • K253082 — LZI Buprenorphine II Enzyme Immunoassay (January 16, 2026)
  • K252520 — SEFRIA™ Hydrocodone Oral Fluid (September 11, 2025)
  • K251972 — Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative (August 15, 2025)
  • K251634 — LZI Fentanyl III Enzyme Immunoassay (June 18, 2025)
  • K240124 — BioSieve™ Fentanyl FIA Test Kit; BioSieve™ ToxiSmart FIA Reader (June 14, 2024)
  • K240698 — Dochek® Multi-Drug Urine Test Dipcard Rx; Dochek® Multi-Drug Urine Test Dipcard (May 10, 2024)
  • K231904 — Rapid Fentanyl (FYL) Test Strip, Rapid Fentanyl (FYL) Test Dipcard (March 8, 2024)
  • K232228 — Multi-drug Urine Test Cup, Multi-drug Urine Test Dip Card, Accurature Multi-drug (February 23, 2024)